From December 13, 2023 to December 31, 2023, the company has repurchased 111,600 shares, representing 0.01% for CNY 1.85 million. With this, the company has completed the repurchase of 111,600 shares, representing 0.01% for CNY 1.85 million under the buyback announced on December 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.85 CNY | -7.26% | -5.20% | -6.82% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.82% | 2.42B | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |
- Stock Market
- Equities
- 603858 Stock
- News Shandong Buchang Pharmaceuticals Co., Ltd.
- Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.